Skip to content

Drug interactions

Imatinib + Panobinostat

Severity: Moderate

Imatinib and Panobinostat: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Imatinib may raise panobinostat exposure through CYP3A4 inhibition. Increased panobinostat levels can worsen diarrhea, thrombocytopenia and QT prolongation.

What this interaction means in plain words

Imatinib and Panobinostat can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Imatinib belongs to Oncology; Panobinostat belongs to Oncology.

Evidence level: Moderate

Why it happens

Imatinib inhibits CYP3A4, which is one of the metabolic pathways of panobinostat.

What to do

Monitor ECG, electrolytes, blood counts and GI toxicity closely. Consider reducing the panobinostat dose, as labeled for strong CYP3A inhibitors, if toxicity emerges.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Imatinib and Panobinostat, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Imatinib with Panobinostat?

MediHelp rates the interaction as moderate. Imatinib and Panobinostat can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Imatinib may raise panobinostat exposure through CYP3A4 inhibition. Increased panobinostat levels can worsen diarrhea, thrombocytopenia and QT prolongation.

How serious is the interaction between Imatinib and Panobinostat?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor ECG, electrolytes, blood counts and GI toxicity closely. Consider reducing the panobinostat dose, as labeled for strong CYP3A inhibitors, if toxicity emerges.

What other medicines interact with Imatinib?

MediHelp also lists interactions of Imatinib with, for example, Lomitapide, Lonafarnib, Amobarbital. The full list is on the Imatinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in